Economist’s fake news on Sinovac efficacy

THE worst fake news, because it clothes itself in half-truths, is that which maliciously does not report information or newer data essential to establishing the facts. This is exactly the case in the British Economist magazine’s April 15 “Daily Chart” section, the least trusted of this magazine’s sections since it often simplifies things to fit into its charts.

The Economist article claimed: “Phase-three trials yielded an efficacy rate (for the Chinese vaccine Sinovac) of just 50.7 percent.” The article’s title made it a tabloid piece: “In clinical and real world trials, China’s Sinovac underperforms.” The clear message: Sinovac doesn’t work; avoid it.